# Cervical cancer trends in Tashkent, 2014 to 2024, from the city oncology register

Source: https://onco.cc/key-papers/paper-mirzaev-tashkent-cervical-registry-2014-2024-jncics-2026/  
OnCo record `paper-mirzaev-tashkent-cervical-registry-2014-2024-jncics-2026` (Key paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

In Tashkent's cancer register, 2,140 women had cervical cancer or carcinoma in situ in 2014 to 2024. After screening projects began, in situ diagnoses rose and advanced-stage disease fell, but three quarters of staged invasive cancers were still stage II to IV.

## Summary

Published as "Population-based registry analysis of cervical cancer trends in Tashkent, Uzbekistan 2014-2024". The authors analysed Tashkent City Oncoregister data for women diagnosed with invasive cervical cancer or carcinoma in situ, calculating age-standardised incidence and mortality and survival, to look at the effect of a Korea Foundation for International Healthcare (KOFIH) screening project and UNFPA and UNDP HPV testing initiatives.

## Fields

- Kind: Key paper
- Last checked: 2026-11-11
- Journal: JNCI Cancer Spectrum
- Year: 2026
- DOI: 10.1093/jncics/pkag107
- Authors: Mirzaev UK, Juraev JR, Sharipova IP, et al.
- Findings: The age-standardised incidence of invasive cervical cancer was 14.9 per 100,000.; After the screening projects began, carcinoma in situ diagnoses rose 3.4-fold and the share of stage III to IV disease fell by 43%.; Five-year survival ranged from 91.5% for carcinoma in situ to 27.8% for stage IV; crude mortality fell from 10.2 to 1.1 per 100,000 between 2014 and 2024.; 76.6% of staged invasive cases were stage II to IV, and more than 80% of women had never been screened.
- What it means: One of the few published analyses of an Uzbek population register, it shows organised screening finding cervical cancer earlier in the capital, and how far coverage still has to go.
- Caveats: One city.; Before and after comparison, not a trial; other changes over the period may contribute.

## Sources

- JNCI Cancer Spectr 2026: https://doi.org/10.1093/jncics/pkag107
- PubMed: https://pubmed.ncbi.nlm.nih.gov/42853092/

## Connected records

- cancers: [Cervical cancer](https://onco.cc/cancers/cervical/)
- institutions: [Uzbekistan national cancer registry (Cancer-registr)](https://onco.cc/institutions/uzbekistan-cancer-registry/)

---
JSON: https://onco.cc/api/v1/entities/paper-mirzaev-tashkent-cervical-registry-2014-2024-jncics-2026.json